Latest news with #F-series
Mint
22-05-2025
- Mint
Poco F7 global variant appears on certification site: Specs and launch timeline leaked
The Poco F7 seems to be inching closer to its global debut, with the device recently surfacing on Thailand's NBTC certification website, reported GSMArena. Reportedly, this new listing suggests both the Poco F7 name and its global model number – 25053PC47G – further cementing speculation that a launch is on the horizon. Though the smartphone was initially expected to arrive in late May, recent developments suggest the unveiling may now take place sometime next month. If launched, the F7 will expand Poco's current F-series lineup, which already includes the F7 Pro and F7 Ultra. Based on multiple leaks and the device's model number, the Poco F7 is widely believed to be a global version of the Redmi Turbo 4 Pro, which was launched in China earlier this year, the publication added. If this holds true, consumers can expect a powerful set of specifications. The handset is tipped to feature a 6.83-inch AMOLED display with a resolution of 1280x2272 pixels, a smooth 120Hz refresh rate, and an impressive peak brightness of 3,200 nits. Under the hood, the Poco F7 is expected to house the Snapdragon 8s Gen 4 chipset, paired with either 12GB or 16GB of RAM and internal storage options ranging from 256GB to a massive 1TB. Camera capabilities are likely to include a 50MP primary sensor, accompanied by an 8MP ultra-wide lens. On the front, a 20MP selfie camera is expected to handle video calls and self-portraits. One of the standout features of the Redmi Turbo 4 Pro is its substantial 7,550mAh battery. However, it remains uncertain whether this specification will be retained in the international version under the Poco branding. With certifications stacking up and rumours gaining momentum, it seems only a matter of time before Poco officially unveils the F7 to global markets. The brand appears set to continue its trend of delivering performance-driven smartphones at competitive price points.
Gulf Insider
13-05-2025
- Automotive
- Gulf Insider
These Are The Favorite Car Brands Of The Ultra-Rich
What car brands do America's wealthiest drivers prefer? While luxury brands may come to mind, data compiled by S&P Global Mobility highlights some interesting findings. In this graphic, Visual Capitalist's Marcu Lu ranks the favorite car brands of the ultra-rich, based on each brand's percentage share of new registrations in the United States. To come up with this analysis, S&P Global Mobility combined income data from the U.S. Census with their own vehicle registration and loyalty data. Ultra-wealthy households are defined as those with annual income of over $500,000. Rank Brand Ultra-Wealthy Market Share(% of new registrations) National Average Market Share(% of new registrations) 1 🇺🇸 Tesla 19.3 4.7 2 🇩🇪 BMW 9.9 2.4 3 🇩🇪 Mercedes-Benz 8.7 1.9 4 🇬🇧 Land Rover 5.8 0.6 5 🇯🇵 Toyota 4.6 14.0 6 🇩🇪 Audi 4.6 1.2 7 🇺🇸 Ford 4.1 9.3 8 🇯🇵 Lexus 3.9 2.6 9 🇩🇪 Porsche 3.9 0.4 10 🇺🇸 Rivian 3.4 0.3 Tesla is the most popular brand among America's ultra-rich, accounting for an impressive 19.3% of new vehicle registrations. This popularity is likely due to Tesla's blend of technology and electric performance, which may resonate with wealthy buyers who value innovation and sustainability. In fact, the ultra-rich are 17.5 percentage points more likely to buy an EV than the average American (85.1% vs 67.7%). This might explain why Rivian, a relatively new car brand, is #10 in this ranking with a 3.4% market share among ultra-rich. Mainstream brands like Toyota and Ford continue to hold strong appeal among America's ultra-rich. These brands can deliver a more practical and reliable experience, and are among the cheapest car brands to own and maintain. Another interesting stat: the Ford F-series pickup truck is the best-selling vehicle in 24 U.S. states.
GSM Arena
08-05-2025
- GSM Arena
Samsung Galaxy F56 unveiled: Exynos 1480 power inside a 7.2mm body
Samsung just announced the Galaxy F56 – at 7.2mm, it is the thinnest F-series phone yet. It is just as thin as the Galaxy M56, to which it is closely related (the M56 launched in mid-April). The Samsung Galaxy F56 is built around a 6.7' OLED display, a 1080p+ 120Hz panel with Gorilla Glass Victus+ protection and up to 1,200 nits in High Brightness Mode. Samsung Galaxy F56 in Violet It is powered by the previous-gen Exynos 1480 with 8GB of LPDDR5X RAM and 128GB or 256GB storage. The phone launches with One UI 7 out of the box (Android 15) and will receive 6 major OS updates. The chipset is cooled by a 'flagship-level vapor chamber'. It runs on a 5,000mAh battery with 45W wired-only charging. The phone's back also uses Victus+ for protection, but the frame is plastic (the camera island is metal, though). The Galaxy F56 is equipped with a 50MP OIS-enabled camera on the back that can record 4K 30fps videos with 10-bit HDR. It also takes Portrait 2.0 photos at 2x zoom. Additionally, Galaxy AI features like Object Eraser and Edit Suggestion are supported. The front-facing camera is a 12MP unit. Samsung Galaxy F56 in Green The F56 supports Samsung Wallet's new Tap & Pay feature. Also, it is secured by Samsung Knox. The Samsung Galaxy F56 launches in India today with two storage options: 8/128GB for ₹26,000 and 8/256GB for ₹29,000. EMI options start at ₹1,556 a month. Source Samsung Galaxy M56 5G
CNBC
06-05-2025
- Business
- CNBC
Stocks making the biggest moves premarket: Palantir Technologies, Ford Motor, Vertex Pharmaceuticals, DoorDash and more
Check out the companies making headlines before the bell. Palantir Technologies – The defense technology stock fell more than 8% after it earned an adjusted 13 cents per share in the first quarter, matching analyst expectations, according to LSEG, while revenue of $884 million topped the $863 million that analysts were looking for. Palantir also boosted its full-year revenue guidance, but FactSet's StreetAccount cited a "lower magnitude of Q1 beat, weaker Europe, slowing customer growth rates, tariffs/trade tensions, and valuation" as causes of the decline. Ford Motor – The F-series pickup truck maker fell more than 2% after it suspended its 2025 guidance , citing "near-term risks, especially the potential for industrywide supply chain disruption impacting production." First-quarter earnings and auto revenue came in better than expected. Other automakers also fell premarket, with General Motors and Stellantis dropping 0.3% and almost 2%, respectively. Tesla moved down nearly 2%. Neurocrine Biosciences – Shares of the biopharmaceutical company jumped nearly 10% after its $572.6 million in revenue for the first quarter topped the $559.6 million that analysts polled by FactSet were expecting. Additionally, sales of Ingrezza, a medication used to treat movement disorders, gained 8% year over year to $545 million. Celsius Holdings – The energy drink maker's stock slid 5.6% on the back of weak first-quarter earnings. Celsius earned 15 cents per share on a GAAP basis, missing the consensus forecast of analysts polled by FactSet by 5 cents a share. Revenue came in at $329.3 million, while Wall Street had penciled in $344.2 million. Hims & Hers Health – Shares lost 6% after the company guided for lighter-than-expected revenue in its second quarter. The telehealth provider forecast revenue to come in between $530 million to $550 million, missing the $564.6 million that analysts polled by FactSet had penciled in. Hims & Hers first-quarter earnings and revenue both beat Street estimates. Vertex Pharmaceuticals – The biotech stock tumbled more than 5% on the heels of weaker-than-expected quarterly results, with adjusted earnings of $4.06 per share below the $4.25 consensus estimate, according to FactSet. Revenue came in at $2.77 billion, missing the consensus estimate of $2.86 billion. Upwork – The stock jumped 10% after the freelance marketplace platform posted first-quarter adjusted earnings of 34 cents per share on revenue of $192.7 million, beating the 27 cents a share on revenue of $188.5 million expected by analysts polled by FactSet. Upwork also raised its full-year adjusted earnings guidance to $1.14 to $1.18 per share from $1.05 to $1.10 a share, also topping analyst estimates. Clorox – The cleaning product maker slid almost 3% after posting disappointing results in its fiscal third quarter, when it earned an adjusted $1.45 per share on revenue of $1.67 billion, short of the $1.57 per share and $1.73 billion in revenue analysts were estimating, according to LSEG. Lattice Semiconductor – The chip stock slipped more than 2% after first-quarter results roughly matched expectations. Adjusted earnings per share of 22 cents were in-line with analyst estimates, according to FactSet, while revenue of $120.2 million compared to an estimate of $120.1 million. Lattice's revenue, net income and gross margin were all down year over year from the same period in 2024. DoorDash – Shares declined more than 3% after first-quarter revenue missed analyst estimates. Adjusted earnings, however, topped expectations. DoorDash also announced a $1.2 billion acquisition of restaurant booking platform SevenRooms, which comes on the heels of British food delivery service Deliveroo also agreeing to a takeover offer from DoorDash. — CNBC's Alex Harring, Jesse Pound, Lisa Kailai Han and Michelle Fox Theobald contributed reporting.
CNBC
05-05-2025
- Business
- CNBC
Stocks making the biggest moves after hours: Palantir Technologies, Ford Motor, Mattel, Clorox and more
Check out the companies making headlines in extended trading. Palantir Technologies — Shares dropped nearly 7% after the defense tech company reported first-quarter earnings that were in line with Wall Street's expectations. Adjusted earnings of 13 cents per share came in-line with the consensus estimate, per LSEG. Palantir reported $884 million in revenue, topping the $863 million forecast by analysts. Vertex Pharmaceuticals — The biotech stock dropped 2% on disappointing quarterly results. Adjusted earnings came in at $4.06 per share, below the $4.32 per share forecast by analysts surveyed by LSEG. Revenue of $2.77 billion also missed analysts' estimates for $2.85 billion. Mattel — Shares of the toymaker declined 2.5% after management paused its 2025 full-year guidance due to tariff uncertainty. Meanwhile, first-quarter results topped analysts' estimates. Neurocrine Biosciences — The maker of neurological drugs jumped 11% postmarket after first-quarter revenue of $572.6 million topped a $559.6 million estimate from analysts surveyed by FactSet. Sales of Ingrezza, used to treat movement disorders, rose 8% year-over-year to $545 million. Lattice Semiconductor — The chip stock fell 3.8% after first-quarter earnings and revenue both were in-line with consensus estimates. Lattice guided toward current quarter revenue between $118.5 million to $128.5 million, while analysts polled by LSEG expected $123.6 million. Adjusted earnings are estimated to range from 22 cents to 26 cents per share, versus the 24 cents per share analysts were looking for. Hims & Hers Health — The telehealth company dropped 1%. Guidance for second-quarter revenue came in lighter than expected, ranging from $530 million to $550 million, while analysts polled by FactSet sought $564.6 million. Earnings and revenue for the first quarter surpassed the Street's expectations, however. Ford Motor — The maker of F-series pickup trucks fell 2.7% after hours on first-quarter results showing earnings ex-items before interest and taxes (EBIT) plunged to $1.02 billion from $2.76 billion a year ago, according to FactSet. Ford estimated the net cost of higher tariffs on EBIT in 2025 at about $1.5 billion and withdrew forward guidance. Clorox – Shares of the cleaning products manufacturer fell 2.8%. Clorox posted adjusted earnings of $1.45 per share on revenue of $1.67 billion in the fiscal third quarter. That fell short of analysts' call for $1.57 per share in earnings and $1.73 billion in revenue, per LSEG. Diamondback Energy – The energy stock advanced nearly 1% after reporting better-than-expected results. Diamondback earned $4.54 per share, ex-items, in the first quarter, topping FactSet consensus estimates for $4.18 per share. Cash capital expenditures of $942 million in the period was less than the $952.8 million forecast by Wall Street. — CNBC's Darla Mercado and Scott Schnipper contributed reporting
